Merck Says Januvia Effective In Type 2 Diabetes
Merck & Co Inc has said that Januvia, its oral, once-daily medicine for type 2 diabetes has shown promise in combating the disease and had significantly reduced //blood sugar levels. This was true when the drug was used alone or in conjunction with two commonly used therapies (metformin or pioglitazone). Merck presented the results of the Phase III trials at the American Diabetes Asso...